CDH

Lokavant Introduces First Source-Agnostic Data Engine to Drive Better Clinical Trial Decision-Making and Improve Performance

Retrieved on: 
Wednesday, January 31, 2024
Software, Research, Professional Services, Pharmaceutical, Technology, Artificial Intelligence, Health Technology, Data Analytics, Clinical Trials, Science, Biotechnology, Health, Other Science, PRIZM, AI, ChromeOS, CDH, Clinical trial, RWD, Drug development, Digital, Artificial intelligence, EDC, Medidata Solutions, Specialization, American Opportunity Tax Credit, SCOPE, CTMS, Medical device

Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.

Key Points: 
  • Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.
  • The life sciences industry struggles to harness enough data to fuel AI for practical uses in clinical research.
  • All trial data is harmonized in PRIZM which fuels Lokavant’s platform to provide a centralized view of trial performance in real time.
  • The industry needs a reliable solution to distill and standardize all the various data sources to drive improved clinical trial decisions.

SharkNinja Announces Pricing of Secondary Offering of Ordinary Shares

Retrieved on: 
Wednesday, December 6, 2023
Consumer Electronics, Retail, Other Consumer, Consumer, Technology, Home Goods, Other Technology, Sale, NYSE, Madison Avenue, William Blair & Company, Telephone, Attention, Security (finance), J. P. Morgan, Jefferies, Varick Street, Morgan Stanley, CDH, Investment, 2nd Floor, Jefferies Group, Prospectus, Guggenheim Partners, Guggenheim, CDH Investments, SharkNinja, L.L.C

SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the pricing of the previously announced secondary offering of 6,095,169 ordinary shares of SharkNinja by certain selling shareholders affiliated with Xuning Wang and CDH Investments (collectively, the “Selling Shareholders”) at a price to the public of $47.00 per ordinary share.

Key Points: 
  • SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the pricing of the previously announced secondary offering of 6,095,169 ordinary shares of SharkNinja by certain selling shareholders affiliated with Xuning Wang and CDH Investments (collectively, the “Selling Shareholders”) at a price to the public of $47.00 per ordinary share.
  • The Selling Shareholder affiliated with CDH Investments has granted the underwriters a 30-day option to purchase up to an additional 914,275 ordinary shares of SharkNinja.
  • SharkNinja is not selling any ordinary shares in the offering and will not receive any of the proceeds from the sale.
  • Goldman Sachs & Co. LLC, J.P. Morgan, Jefferies and Morgan Stanley are acting as joint lead book-running managers for the offering.

SharkNinja Announces Launch of Secondary Offering of Ordinary Shares

Retrieved on: 
Monday, December 4, 2023
Other Consumer, Technology, Other Retail, Other Technology, Home Goods, Lifestyle, Consumer, Retail, Consumer Electronics, Sale, NYSE, Madison Avenue, William Blair & Company, Telephone, Attention, Security (finance), J. P. Morgan, Form, Jefferies, Varick Street, Morgan Stanley, CDH, Investment, 2nd Floor, Jefferies Group, SEC filing, Prospectus, Guggenheim Partners, Guggenheim, CDH Investments, SharkNinja, L.L.C

Additionally, the Selling Shareholder affiliated with CDH Investments intends to grant the underwriters a 30-day option to purchase up to an additional 841,896 ordinary shares of SharkNinja.

Key Points: 
  • Additionally, the Selling Shareholder affiliated with CDH Investments intends to grant the underwriters a 30-day option to purchase up to an additional 841,896 ordinary shares of SharkNinja.
  • SharkNinja is not selling any ordinary shares in the offering and will not receive any of the proceeds from the sale.
  • Goldman Sachs & Co. LLC, J.P. Morgan, Jefferies and Morgan Stanley are acting as joint lead book-running managers for the proposed offering.
  • The proposed offering of these securities will be made only by means of a prospectus.

DataPath and Health-E Commerce join forces to enhance FSA and HSA user experience with frictionless technology solutions

Retrieved on: 
Thursday, December 14, 2023
Well, COBRA, HSA, CDH, Commerce, Balance, IRS, FSA, Currency strap, Partnership, ROCK, Datapath, Online shopping, Management, Summit

DataPath has been helping clients get where they want to grow for nearly 40 years through innovative solutions that address ever-changing market conditions.

Key Points: 
  • DataPath has been helping clients get where they want to grow for nearly 40 years through innovative solutions that address ever-changing market conditions.
  • DataPath is the only platform provider that is an end-to-end card and payment processor, and DataPath Financial Services, Inc. is an IRS-approved HSA non-bank custodian.
  • When logged in to Summit, employee participants can connect directly to FSA Store or HSA Store to spend account funds.
  • "We're proud to partner with DataPath to help consumers and employers realize greater value from their tax-advantaged healthcare accounts."

Spear Bio, developer of the next-generation ultrasensitive immunodiagnostics and proteomics platform, completes raise of tens of millions of US dollars with oversubscribed Seed Prime

Retrieved on: 
Wednesday, November 29, 2023
Microfluidics, DBS, Immunity, Research, DNA, Conditional sentence, Proteomics, Investment, Protein, Reproductive success, Disease, CDH, Patient, Multimedia, Neurology, Laboratory, SPEAR, Harvard University, Infection, COVID-19, Workflow, Ultra, Biomarker, Real-time, Wyss Institute, ELISA, Partnership, CDH Investments, Pharmaceutical industry, Medical imaging, Hunting

The oversubscribed round was led by CDH Investments, with additional investments from earlier investors such as Maverick Ventures and YongHua Capital.

Key Points: 
  • The oversubscribed round was led by CDH Investments, with additional investments from earlier investors such as Maverick Ventures and YongHua Capital.
  • Spear Bio was co-founded in March 2021 as a spin-off from Harvard University's Wyss Institute by Professor Peng Yin and Dr. Feng Xuan.
  • The company is developing the next generation ultrasensitive immunodiagnostics and proteomics platform based on a breakthrough technology its founders developed and licensed from Harvard University: the Successive Proximity Extension Amplification Reaction, or SPEAR.
  • Spear Bio is now focused on bringing to market ultrasensitive immunoassays for areas such as neurology, immunology, and oncology.

BAYER WELCOMES ANTOINE BERNET AS NEW COUNTRY DIVISION HEAD FOR CROP SCIENCE CANADA

Retrieved on: 
Tuesday, August 8, 2023
Marketing, Agriculture, Crop protection, AB, Research, CDH, Agricultural science, Growth, Climate, Bayer, Bernet

CALGARY, AB, Aug. 8, 2023 /CNW/ - The Crop Science division of Bayer announced that Antoine Bernet, has been appointed the Country Division Head (CDH) for Crop Science Canada, effective August 1, 2023.

Key Points: 
  • CALGARY, AB, Aug. 8, 2023 /CNW/ - The Crop Science division of Bayer announced that Antoine Bernet, has been appointed the Country Division Head (CDH) for Crop Science Canada, effective August 1, 2023.
  • Moving to Canada to lead this dynamic organization is a tremendous opportunity for me personally and professionally," said Antoine Bernet, CDH for Crop Science Canada.
  • Bernet began his career with Bayer more than 20 years ago, joining the Crop Science division in 2005.
  • Bernet succeeds Al Driver, former CDH, Crop Science Canada who will retire from Bayer at the end of the year.

OneSource Virtual Joins Highline's Payroll Payments Network to Deliver Solutions for Employee Financial Health and Well-being

Retrieved on: 
Wednesday, August 2, 2023
OSV, Organization, CFO, William Billers, Partnership, Paycheck, OneSource, LendingClub, ACH, Pay As You Earn, CDH, Bank, DALLAS

DALLAS, Aug. 2, 2023 /PRNewswire-PRWeb/ -- OneSource Virtual (OSV), the leading provider of services for Workday, and an innovator of extensible applications built on Workday technology, announces a first-of-its-kind partnership with Highline, a fintech company transforming payments to benefit consumers and billers alike. This collaboration enables OneSource Virtual customers to further improve the financial health and well-being of their employees with Highline's revolutionary new payments network, which powers Pay by Paycheck, designed to simplify consumer finances between payday and bill due dates.

Key Points: 
  • This collaboration enables OneSource Virtual customers to further improve the financial health and well-being of their employees with Highline's revolutionary new payments network, which powers Pay by Paycheck, designed to simplify consumer finances between payday and bill due dates.
  • "One of our core missions is to deliver innovative solutions that drive employee financial wellness in the U.S. market," explains John Bax, CFO of OneSource.
  • Highline's Pay by Paycheck enables consumers to make payments directly from their paycheck, bypassing the traditional banking and payment rails.
  • Geoff Brown shared in the sentiment, "Highline is very grateful to OSV for building such a deep partnership with us.

Smart Share Global Limited Announces First Quarter 2023 Results

Retrieved on: 
Tuesday, June 20, 2023
Columbia University, Maintenance, Advertising, International Finance Corporation, Marketing, China International Capital Corporation, Kas, MBA, Fruit, CDH, US, World Bank Group, POI, Investment, Fudan University, Webcast, Reye syndrome, Depreciation, Growth, Research, Ali Baba, NYSE, Cryptocurrency, Reinsurance, Video game, Drug, Management, Internet service provider

SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended March 31, 2023.

Key Points: 
  • SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended March 31, 2023.
  • As of March 31, 2023, cumulative registered users reached 347.2 million, with 13.5 million newly registered users acquired during the quarter.
  • “During the quarter, we remain committed to expanding our coverage and improving efficiency to drive growth and achieve our strategic goals.
  • The company will hold a conference call at 8:00 A.M. Eastern Time on Tuesday, June 20, 2023 (8:00 P.M. Beijing Time on Tuesday, June 20, 2023) to discuss the financial results.

BEST Inc. Announces Changes to its Board of Directors

Retrieved on: 
Wednesday, May 24, 2023
Columbia University, International Finance Corporation, Culture, China International Capital Corporation, MIT Blackjack Team, MBA, CDH, NYSE, World Bank Group, Fudan University, Ecosystem, Annual report, Management, Ali Baba

Mr. Wan has confirmed that he has no disagreement with the Company's board of directors (the "Board") and there is no other matter relating to his resignation that needs to be brought to the attention of the Company's shareholders.

Key Points: 
  • Mr. Wan has confirmed that he has no disagreement with the Company's board of directors (the "Board") and there is no other matter relating to his resignation that needs to be brought to the attention of the Company's shareholders.
  • Prior to his resignation, Mr. Wan served as a member of the compensation committee, and as a member of the corporate governance and nominating committee, of the Board.
  • "We wish him the best of success in his future endeavors."
  • These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements.

Zevra Therapeutics Announces Collaboration with RARE-X and the Sleep Consortium as Founding Member of New Sleep Data Initiative

Retrieved on: 
Friday, March 17, 2023
Acceleration, 1836 U.S. Patent Office fire, Patent, Partnership, Drug development, Consortium, Idiopathic hypersomnia, Sole, United States Patent and Trademark Office, Sleep, IH, Narcolepsy, Data collection, Research, CDH, Methylphenidate, Patient, Somnolence, SDX, Ecosystem, Salt, Therapy, Phenotype, Global Genes, Treatment, Disease, Pharmaceutical industry, Zebra

CELEBRATION, Fla., March 17, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (formerly KemPharm, Inc.), a rare disease therapeutics company, today announced that it has joined the Sleep Data Initiative as a founding member. The new data collection platform is led by RARE-X and the Sleep Consortium to provide access to research-grade, patient-owned data to support the acceleration of research and treatment development for sleep disorders.

Key Points: 
  • The new data collection platform is led by RARE-X and the Sleep Consortium to provide access to research-grade, patient-owned data to support the acceleration of research and treatment development for sleep disorders.
  • “Marking World Sleep Day today, we are proud to announce this important collaboration and our role as a founding member of this significant initiative to support acceleration and advancement of sleep research programs,” said Richard W. Pascoe, Chief Executive Officer of Zevra.
  • Sleep Consortium is a not-for-profit organization working to support research and drug development for Central Disorders of Hypersomnolence (CDH) and other related sleep disorders.
  • “As a founding member of the Sleep Data Initiative, Zevra Therapeutics recognizes the need for collaboration to develop creative solutions to improve the lives of patients with sleep disorders,” said Lindsay Jesteadt, Ph.D., Chief Executive Officer and Co-Founder of Sleep Consortium.